<p>(A) Scheme depicting the virus and nAb-specific parameters necessary to predict HIV-1 neutralization by nAbs <i>in silico</i>. (B) to (D) Predicted HIV-1 nAb neutralization curves in dependence of (B) nAb K<sub>D</sub>, (C) HIV-1 entry stoichiometry, T, and (D) mean viron trimer number, . (E) Dependence of nAb IC50 on the number of Env trimers required for HIV-1 cell entry, T. (F) Relation between HIV-1 virion population size and the fraction of Env subunits that need to be bound by nAb to achieve virus population neutralization. (G) Comparison of experimental nAb IC50 values measured with HIV-1 strain BG505 [<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1006313#ppat.1006313.ref047" target="_blank">47</a>, <...
Broadly neutralizing antibodies are promising candidates for treatment and prevention of HIV-1 infec...
<p>(A) Samples are ranked by their neutralization score on the 37-virus panel (37vP) (S4 Fig in <a h...
<p>(A) Model predictions for male to female per-act HIV-1 transmission risk in absence of nAbs and i...
<p>(A) Scheme depicting the combined experimental-mathematical approach employed here to estimate N....
The broadly neutralizing antibody (bnAb) VRC01 is being evaluated for its efficacy to prevent HIV-1 ...
The potential of broadly neutralizing antibodies targeting the HIV-1 envelope trimer to prevent HIV-...
SummaryEfforts to prevent human immunodeficiency virus type 1 (HIV-1) infection would benefit from u...
The broadly neutralizing antibody (bnAb) VRC01 is being evaluated for its efficacy to prevent HIV-1 ...
HIV is a highly mutable virus for which all attempts to develop a vaccine have been unsuccessful. Ne...
AbstractTrimers of the HIV-1 envelope glycoprotein (Env) effectuate viral entry into susceptible cel...
Held in conjunction with the 16th International Parallel and Distributed Processing Symposium Copyri...
HIV is a highly mutable virus for which all attempts to develop a vaccine have been unsuccessful. Ne...
The ongoing Antibody Mediated Prevention (AMP) trials will uncover whether passive infusion of the b...
Advances in single-cell antibody cloning methods have led to the identification of a variety of broa...
<p>The fraction neutralized is plotted against the concentration of Fab sites. The inserts in A, B a...
Broadly neutralizing antibodies are promising candidates for treatment and prevention of HIV-1 infec...
<p>(A) Samples are ranked by their neutralization score on the 37-virus panel (37vP) (S4 Fig in <a h...
<p>(A) Model predictions for male to female per-act HIV-1 transmission risk in absence of nAbs and i...
<p>(A) Scheme depicting the combined experimental-mathematical approach employed here to estimate N....
The broadly neutralizing antibody (bnAb) VRC01 is being evaluated for its efficacy to prevent HIV-1 ...
The potential of broadly neutralizing antibodies targeting the HIV-1 envelope trimer to prevent HIV-...
SummaryEfforts to prevent human immunodeficiency virus type 1 (HIV-1) infection would benefit from u...
The broadly neutralizing antibody (bnAb) VRC01 is being evaluated for its efficacy to prevent HIV-1 ...
HIV is a highly mutable virus for which all attempts to develop a vaccine have been unsuccessful. Ne...
AbstractTrimers of the HIV-1 envelope glycoprotein (Env) effectuate viral entry into susceptible cel...
Held in conjunction with the 16th International Parallel and Distributed Processing Symposium Copyri...
HIV is a highly mutable virus for which all attempts to develop a vaccine have been unsuccessful. Ne...
The ongoing Antibody Mediated Prevention (AMP) trials will uncover whether passive infusion of the b...
Advances in single-cell antibody cloning methods have led to the identification of a variety of broa...
<p>The fraction neutralized is plotted against the concentration of Fab sites. The inserts in A, B a...
Broadly neutralizing antibodies are promising candidates for treatment and prevention of HIV-1 infec...
<p>(A) Samples are ranked by their neutralization score on the 37-virus panel (37vP) (S4 Fig in <a h...
<p>(A) Model predictions for male to female per-act HIV-1 transmission risk in absence of nAbs and i...